What is multisystem inflammatory syndrome in children in the context of COVID-19?

Multisystem inflammatory syndrome (MIS) is a rare but serious condition associated with COVID-19 in which different body parts become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. MIS can affect children (MIS-C) and adults (MIS-A).

Is it common to develop multisystem inflammatory syndrome (MIS) after recovering from COVID-19?

While it is very rare, some people, mostly children, experience multisystem inflammatory syndrome (MIS) during or immediately after a COVID-19 infection. MIS is a condition where different body parts can become inflamed.

What is multisystem inflammatory syndrome in adults (MIS-A) and how is it related to COVID-19?

This new and serious syndrome, called multisystem inflammatory syndrome in adults (MIS-A), occurs in adults who were previously infected with the COVID-19 virus and many didn’t even know it. MIS-A seems to occur weeks after COVID-19 infection, though some people have a current infection.

When does MIS-C symptoms manifest in relation with COVID-19 infection?

MIS-C usually affects school-age children, most commonly 8- and 9-year-olds, but the syndrome also has been seen in infants and young adults. MIS-C symptoms appear between two and six weeks (four weeks on average) after COVID-19 infection. Most children with MIS-C have antibodies to the SARS-CoV-2 virus.

How long after being infected with COVID-19 can multisystem inflammatory syndrome in adults (MIS-A) occur?

Is multisystem inflammatory syndrome (MIS) associated with COVID-19?

Multisystem inflammatory syndrome (MIS) can affect children (MIS-C) and adults (MIS-A). MIS is a rare but serious condition associated with COVID-19 in which different body parts become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs.

Can symptoms of COVID-19 present with gastrointestinal symptoms?

Some studies have shown that GI symptoms can manifest before the onset of typical respiratory symptoms [2,59]. The first confirmed case of COVID-19 in the US presented with a two-day history of nausea without respiratory complaint.